Decent Drugs Private Limited - Company Profile

It is a chemicals and materials private limited company based in Yamuna Nagar, Haryana, India, established in 2008.
2008 Yamuna Nagar, Haryana, India Active
Last Updated:
Access Report
About Decent Drugs Private Limited

Decent Drugs Private Limited, a active private limited company, was established on 11 July 2008 in Yamuna Nagar, Haryana, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24233HR2008PTC038155. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.74 M.

It upholds a compliant status. Its leadership includes Darshan Pal Bansal (Director), Ekta Bansal (Director). Past directors included Laxman Vinaik, Ekta Bansal. It holds ₹8.80 M open charges and no settled loans. Its latest AGM occurred on 12 August 2024, with the balance sheet filed on 31 March 2024. It is based at 20 E Industrial Area Near Bus Stand, Yamuna Nagar, Haryana, 135001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233HR2008PTC038155

  • Registration Number

    038155

  • Incorporation Date

    11 July 2008

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹9.74 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 9.74 M
  • Company Age 17 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 8.80 M
  • Revenue Growth **** -18.62%
  • Profit Growth **** 113.67%
  • Ebitda **** 52.16%
  • Net Worth 0.57%
  • Total Assets -8.20%
Company report

Decent Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Decent Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Decent Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Darshan Pal Bansal Director 11 Jul 2008 Current
Ekta Bansal Director 08 Mar 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Mar 2013 Past
Pramod Abcsdd Additional Director 30 Sep 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Decent Drugs.

Decent Drugs Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 18.62% decrease. The company also saw a substantial improvement in profitability, with a 113.67% increase in profit. The company's net worth moved up by a moderate rise of 0.57%.

Decent Drugs revenue growth over time
Decent Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -18.62%
*******
*******
*******
*******
Revenue from Operations
*******
 -19.08%
*******
*******
*******
*******
Total Assets
*******
 -8.20%
*******
*******
*******
*******
Profit or Loss
*******
 113.67%
*******
*******
*******
*******
Net Worth
*******
 0.57%
*******
*******
*******
*******
EBITDA
*******
 52.16%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Decent Drugs?

In 2019, Decent Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹8,800,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of Patiala Sme Branch : 0.88 Cr
Latest Charge Details
Date Lender Amount Status
19 Feb 2009 State Bank Of Patiala Sme Branch ₹8.80 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Decent Drugs?

Unlock and access historical data on people associated with Decent Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Decent Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Decent Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Decent Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Decent Drugs Private Limited last Annual general meeting of members was held on 12 Aug 2024 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Decent Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.

  • Charges

    The activity A charge with State Bank Of Patiala Sme Branch of Rs. 0.88 Cr registered on 19 Feb 2009 with Charge ID 10143583 was modified on 15 Feb 2016. was completed.

  • Director Appointment

    The activity Ekta Bansal was appointed as a Director was appointed as a Director on 08 Mar 2013 & has been associated with this company since 12 years 11 months . was completed.

  • Charges

    Progress on A charge with State Bank Of Patiala Sme Branch amounted to Rs. 0.88 Cr with Charge ID 10143583 was registered on 19 Feb 2009. was documented.

  • Director Appointment

    Darshan Pal Bansal was appointed as a Director was appointed as a Director on 11 Jul 2008 & has been associated with this company since 17 years 7 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Decent Drugs Private Limited?

The CIN of Decent Drugs Private Limited is U24233HR2008PTC038155.

Where is Decent Drugs Private Limited headquartered?

Decent Drugs Private Limited is headquartered at 20 E Industrial Area Near Bus Stand, Yamuna Nagar, Haryana, 135001.

When was Decent Drugs Private Limited incorporated?

Decent Drugs Private Limited was incorporated on 11 July 2008.

Who are the current directors of Decent Drugs Private Limited?

The current directors of Decent Drugs Private Limited are

What is the primary industry of Decent Drugs Private Limited?

The primary industry of Decent Drugs Private Limited is Manufacturing.

Is Decent Drugs Private Limited a listed company?

Decent Drugs Private Limited is unlisted.

What is the capital structure of Decent Drugs Private Limited?

The authorized capital of Decent Drugs Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.74 M.

What is the compliance status of Decent Drugs Private Limited?

The compliance status of Decent Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available